150 related articles for article (PubMed ID: 30854130)
1. Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer.
Liu Q; Luo D; An H; Zhang S; Cai S; Li Q; Li X
J Cancer; 2019; 10(5):1209-1215. PubMed ID: 30854130
[No Abstract] [Full Text] [Related]
2. Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis.
Zhou H; Wang S; Cai Z; Qiu E; Chen Q; Rao X; Han S; Li Z
Int J Colorectal Dis; 2022 Dec; 37(12):2481-2489. PubMed ID: 36334109
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Guiding Role of Elevated Pretreatment Serum Carcinoembryonic Antigen Levels for Adjuvant Chemotherapy in Stage IIA Colon Cancer: A Large Population-Based and Propensity Score-Matched Study.
Liu Q; Huang Y; Luo D; Zhang S; Cai S; Li Q; Ma Y; Li X
Front Oncol; 2019; 9():37. PubMed ID: 30815388
[No Abstract] [Full Text] [Related]
4. Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database.
Huang B; Feng Y; Zhu L; Xu T; Huang L; Cai G
Int J Surg; 2016 Sep; 33 Pt A():157-63. PubMed ID: 27491969
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis.
Zhou K; Zhao Y; Liang L; Cao J; Lin H; Peng Z; Mei J
Front Oncol; 2022; 12():938195. PubMed ID: 36119504
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients.
Chen X; Tu J; Xu X; Gu W; Qin L; Qian H; Jia Z; Ma C; Xu Y
Front Oncol; 2022; 12():874749. PubMed ID: 35747799
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
8. Survival Contradiction Between Stage IIA and Stage IIIA Rectal Cancer: A Retrospective Study.
Mo S; Dai W; Xiang W; Huang B; Li Y; Feng Y; Li Q; Cai G
J Cancer; 2018; 9(8):1466-1475. PubMed ID: 29721057
[No Abstract] [Full Text] [Related]
9. Mucinous Histology Might Be an Indicator for Enhanced Survival Benefit of Chemotherapy in Stage II Colon Cancer.
Huang Y; Ge K; Fu G; Chu J; Wei W
Front Med (Lausanne); 2020; 7():205. PubMed ID: 32582726
[No Abstract] [Full Text] [Related]
10. Heterogeneous survival between stage IIA and stage IIIA colon cancer when different numbers of lymph nodes are harvested.
Huang B; Feng Y; Ni M; Chen C; Cai G
ANZ J Surg; 2018 Apr; 88(4):316-321. PubMed ID: 27580642
[TBL] [Abstract][Full Text] [Related]
11. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study based on SEER database: not all high-risk factors are equal for stage II colon cancer.
Li D; Jiang Z; Xiang L; Yang C; Long F; Liu W
Transl Cancer Res; 2022 Apr; 11(4):689-698. PubMed ID: 35571652
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF
Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273
[TBL] [Abstract][Full Text] [Related]
14. Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries.
Eheman CR; O'Neil ME; Styles TS; Thompson TD; Morris CR; Babcock FA; Chen VW
J Registry Manag; 2016; 43(4):179-186. PubMed ID: 29308117
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Radiation Survival Benefits in Patients with Stage 1B Rectal Cancer: A Population-based Study from the Surveillance Epidemiology and End Result Database (1973-2010).
Waheed A; Cason FD
Cureus; 2019 Dec; 11(12):e6299. PubMed ID: 31938592
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General Population.
Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):e29-e38. PubMed ID: 27663601
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
[TBL] [Abstract][Full Text] [Related]
19. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
20. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
